BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing
01. Februar 2023 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Feb. 01, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTCQB: BSEM), a leading regenerative medicine company focused on the development,...
BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
15. November 2022 16:05 ET
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on November 15, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
15. November 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe
08. September 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies to Host Second Quarter Financial Results and Corporate Update Conference Call on August 22nd
16. August 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Inc. Reports December 31, 2021 Year End Financial Results
01. April 2022 10:00 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., April 01, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioRestorative Therapies Named One of Ten Most Innovative Regenerative Medicine Companies in 2022 by Insights Care Magazine
26. Januar 2022 06:00 ET
|
BioRestorative Therapies, Inc
MELVILLE, N.Y., Jan. 26, 2022 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company" or “BioRestorative”) (NASDAQ:BRTX), a life sciences company focused on adult stem cell-based...